Cernilton for benign prostatic hyperplasia

Reason for withdrawal from publication Authors have indicated they are not going to update this review. To view the published versions of this article, please click the 'Other versions' tab. Raison du retrait de la publication Cernilton dans l'hyperplasie prostatique benigne Les auteurs ont indique qu'ils ne mettraient pas a jour la presente revue. Pour voir les versions publiees de cet article, veuillez cliquer sur l'onglet « Other versions ».

[1]  G. Chodak,et al.  Saw palmetto (Serenoa repens) in men with lower urinary tract symptoms: effects on urodynamic parameters and voiding symptoms. , 1998, Urology.

[2]  A. C. Buck.  Phytotherapy for the prostate. , 1996, British journal of urology.

[3]  D K Menon,et al.  Survey of intensive care of severely head injured patients in the United Kingdom , 1996, BMJ.

[4]  D. Rennie,et al.  The Cochrane Collaboration. Preparing, maintaining, and disseminating systematic reviews of the effects of health care. , 1995, JAMA.

[5]  R. J. Hayes,et al.  Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. , 1995, JAMA.

[6]  J. Oesterling,et al.  Benign prostatic hyperplasia. Medical and minimally invasive treatment options. , 1995, The New England journal of medicine.

[7]  A. C. Buck,et al.  Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study. , 1990, British journal of urology.

[8]  F Mosteller,et al.  Some Statistical Methods for Combining Experimental Results , 1990, International Journal of Technology Assessment in Health Care.

[9]  I. Kimura,et al.  Micturition activity of pollen extract: contractile effects on bladder and inhibitory effects on urethral smooth muscle of mouse and pig. , 1986, Planta medica.

[10]  P. Walsh,et al.  The development of human benign prostatic hyperplasia with age. , 1984, The Journal of urology.

[11]  S. Dutkiewicz.  Usefulness of Cernilton in the treatment of benign prostatic hyperplasia , 2006, International Urology and Nephrology.

[12]  H. Kawanishi,et al.  Clinical evaluation of long-term treatment using cernitin pollen extract in patients with benign prostatic hyperplasia. , 1995, Clinical therapeutics.

[13]  R. Bruskewitz,et al.  Benign prostatic hyperplasia: diagnosis and treatment (Clinical practice guideline no. 8; AHCPR publication no. 94-0582) , 1994 .

[14]  H. Guess.  Benign prostatic hyperplasia: antecedents and natural history. , 1992, Epidemiologic reviews.